Immune globulin sulfonated human (Kaketsuken/Teijin)

N/A

Report date: 2026/02/24 20:00:16

Base Information

Drug NameImmune globulin sulfonated human (Kaketsuken/Teijin)
Drug Alias NameIVIG - Kaketsuken/TeijinSulfonated human immunoglobulinFreeze-dried sulfonated human immunoglobulinVenilonKenketsu Venilon-I +[10] 
ClassificationBiologics > Protein drugs > ImmunoglobulinBiologics > Blood components
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMultifocal Motor NeuropathyWHIM syndromeAgammaglobulinemia +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1979/05/22
Country/TerritoryJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesKM Biologics Co LtdTeijin Pharma
China Registration ClassN/A

Develop Information

Active CompaniesKM Biologics Co Ltd
Inactive CompaniesN/A
Active IndicationsMultifocal Motor NeuropathyWHIM syndromeAgammaglobulinemia +[8] 
Inactive IndicationsN/A

Other Information

ATC CodeJ06BA02
Related LinksN/A